Chemistry:AS-601811
From HandWiki
AS-601811 is a 5α-reductase inhibitor of type 1 of the enzyme which was under development for the treatment of acne, benign prostatic hyperplasia, hirsutism, male-pattern baldness, and prostate cancer but was never marketed.[1][2] It is taken orally.[1] The drug reached phase 1 clinical trials prior to the discontinuation of its development.[1] It was being developed by Merck Serono.[1][2]
See also
- List of investigational hair loss drugs
- Epristeride
- MK-434
References
- ↑ 1.0 1.1 1.2 1.3 "AS 601811". 12 March 2008. https://adisinsight.springer.com/drugs/800013228.
- ↑ 2.0 2.1 "5a-Reductase and Its Inhibitors". Acne and Its Therapy. CRC Press. 17 May 2007. pp. 181–216. doi:10.3109/9781420018417-18. ISBN 978-0-429-16389-0. https://www.taylorfrancis.com/books/9781420018417/chapters/10.3109/9781420018417-18. Retrieved 23 October 2025.
 |  |
